Pulmatrix, Inc. Common Stock (PULM) is a publicly traded Healthcare sector company. As of May 21, 2026, PULM trades at $1.27 with a market cap of $4.60M and a P/E ratio of -0.90. PULM moved +0.79% today. Year to date, PULM is -44.05%; over the trailing twelve months it is -80.28%. Its 52-week range spans $1.16 to $10.40. Rallies surfaces PULM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Pulmatrix Agrees Q3 Merger with Eos, Secures $1 Million Preferred, 6% Stake: Pulmatrix entered a merger agreement with Eos SENOLYTIX on March 26, securing $1 million from a Series B preferred stock private placement and granting common shareholders approximately 6% interest in the combined company, expected to close in Q3 2026. Q1 R&D expenses remained under $0.1 million while G&A spending declined 28% to $1.3 million.
| Metric | Value |
|---|---|
| Price | $1.27 |
| Market Cap | $4.60M |
| P/E Ratio | -0.90 |
| EPS | $-1.41 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.40 |
| 52-Week Low | $1.16 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-5.16M |
| Gross Margin | 0.00% |
PULM analyst coverage data. Average price target: $0.00.